Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL

Saatavilla:

Hospira Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

irinotecan hydrochloride trihydrate

Lääkemuoto:

Injection, intravenous infusion

Koostumus:

Excipient Ingredients: lactic acid; sorbitol; water for injections

Antoreitti:

Intravenous Infusion

Kpl paketissa:

1 x 5 mL vial

luokka:

Medicine Listed (Export Only)

Prescription tyyppi:

(S1) This Schedule is intentionally blank

Käyttöaiheet:

Small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non Hodgkin's disease).

Tuoteyhteenveto:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Valtuutuksen tilan:

Listed (Export Only)

Valtuutus päivämäärä:

2013-01-30